Health Care: Drugs

Biogen Idec Inc (BIIB: NASDAQ)

$409.59 n/a | n/a%
02/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 8.51B 5.81B 4.38B 5.05B
Cost of Sales 972.65M 668.93M 382.05M 316.41M
Gross Operating Profit 7.54B 5.14B 4.00B 4.73B
Selling, General, and Administrative Expenses 2.23B 1.80B 1.28B 1.37B
Research & Development 1.89B 1.44B 1.33B 1.22B
Operating Income before D & A (EBITDA) 3.41B 1.90B 1.38B 2.14B
Depreciation & Amortization 688.15M 531.74M 365.65M 358.93M
Interest Income 12.20M 8.20M 29.50M 19.20M
Other Income - Net 1.19B 1.12B 841.36M -35.74M
Special Income / Charges 38.89M 547.00K 0.00 0.00
Total Income Before Interest Expenses (EBIT) 3.96B 2.50B 1.89B 1.74B
Interest Expense 29.50M 31.90M 36.50M 33.00M
Pre-Tax Income 3.93B 2.46B 1.85B 1.71B
Income Taxes 989.94M 601.01M 470.55M 444.53M
Minority Interest 6.78M 0.00 0.00 32.26M
Net Income From Continuing Operations 2.94B 1.86B 1.38B 1.27B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.94B 1.86B 1.38B 1.27B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.93B 1.86B 1.38B 1.23B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.90B 1.86B 1.38B 1.29B
Preferred Dividends
Net Income Available To Common 2.94B 1.86B 1.38B 1.27B
Basic EPS from Continuing Ops. 12.42 7.86 5.80 5.09
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 12.42 7.86 5.80 5.09
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 12.42 7.86 5.80 5.09
Basic Normalized Net Income/Share 12.25 7.86 5.81 5.17
EPS fr Continuing Ops. 12.37 7.81 5.76 5.04
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 12.37 7.81 5.76 5.04
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 12.37 7.81 5.76 5.04
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
12.21 7.81 5.77 5.11
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BIIB

Latest BIIB Headlines from TheStreet

More Financial News for BIIB

Press Releases for BIIB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter